Prevalence of and risk factors for antimicrobial resistance in pneumococcal disease in southern Ontario during the PCV13 era
In our population, pneumococcal antimicrobial resistance has remained relatively stable, but changes differ by antibiotic class. Implementation of vaccination programs with PCV20 or PCV21 should reduce AMR by disease prevention.
Authors
- George Zhanel
- Karen A. Green
- Altynay Shigayeva
- Angel Xinliu Li
- Tamara Vikulova
- Brenda L. Coleman (ORCID: https://orcid.org/0000-0002-7144-4827)
- Alyssa Golden (ORCID: https://orcid.org/0000-0002-1788-1794)
- Lubna Farooqi
- Sarah Nayani (ORCID: https://orcid.org/0000-0002-4842-9645)
- Maxime Lefebvre
- Zoë Zhong
- Neil Rau
- Reena Lovinsky
- Kevin Katz
- Amna Faheem
- Daniel Ricciuto
- Christie Vermeiren
- Asfia Sultana
- Irene Martin
- David Richardson
- Kazi Hassan
- Krystyna Ostrowska
- Christopher Kandel
- Agron Plevneshi
- Allison McGeer
- Nadia Malik
- Matthew P. Muller
- Wayne L. Gold
- Heather Adam
Institutions
- University Health Network (CA)
- Public Health Agency of Canada (CA)
- University of Toronto (CA)
- Scarborough Health Network (CA)
- Lakeridge Health (CA)
- North York General Hospital (CA)
- Trillium Health Centre (CA)
- Toronto General Hospital (CA)
- Toronto East General Hospital (CA)
- Public Health Ontario (CA)
- William Osler Health System (CA)
- Sinai Health System (CA)
- HalTech (CA)
- University of Manitoba (CA)
Publication Details
- Journal
- Vaccine
- Published
- 2026-03-04
- DOI
- https://doi.org/10.1016/j.vaccine.2026.128351
- Primary Topic
- Pneumonia and Respiratory Infections
- Type
- article
- Field-Weighted Citation Impact
- 0.00